Cell Therapy in Limb Girdle Muscular Dystrophy
NCT02245711 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2018-10-25
Summary
The purpose of this study was to study the effect of stem cell therapy on Limb Girdle Muscular Dystrophy patients.
Conditions
- Limb Girdle Muscular Dystrophy
Interventions
- BIOLOGICAL
-
Stem Cell
Sponsors & Collaborators
-
Neurogen Brain and Spine Institute
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 15 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-06-30
Countries
- India
Study Locations
More Related Trials
-
Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
NCT01834040 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia
NCT01958177 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cell Therapy in Multiple System Atrophy
NCT02315027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
NCT02917681 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2
NCT02484560 ·Status: UNKNOWN ·Phase: PHASE1
-
Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT01142856 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Limb-Girdle Muscular Dystrophy
NCT00893334 ·Status: COMPLETED
-
Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis
NCT04293484 ·Status: COMPLETED ·Phase: NA
-
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
NCT06532474 ·Status: RECRUITING
-
Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)
NCT06765564 ·Status: RECRUITING ·Phase: NA
-
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
NCT03067831 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mechanisms of Cell Death in Spinal Muscular Atrophy
NCT01754441 ·Status: COMPLETED
-
Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients
NCT02987413 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
NCT01610440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
NCT03268603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
NCT06321965 ·Status: RECRUITING ·Phase: NA
-
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
NCT02235844 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
NCT00468832 ·Status: UNKNOWN
-
Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia
NCT04385056 ·Status: UNKNOWN ·Phase: PHASE1
-
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
NCT05167721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy
NCT02285673 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Expanded Access Study of UC-MSC in DMD Patients
NCT06579352 ·Status: AVAILABLE
-
Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I
NCT03842878 ·Status: COMPLETED
-
The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis
NCT01494480 ·Status: UNKNOWN ·Phase: PHASE2